naltrexone has been researched along with Cerebral Ischemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Min, JW; Qiao, F; Wang, D; Wang, H | 1 |
| Dong, HP; He, ZZ; Ma, XX; Wang, ZH; Zhou, W | 1 |
| Golaghaei, A; Hosseini, SM; Mohammadi, S; Naderi, N; Nassireslami, E; Pourbadie, HG; Rahimzadegan, M | 1 |
| Castaño-Duque, CH; Dávalos, A; Dorado-Bouix, L; García-Esperón, C; Gomis-Cortina, M; Hervás-García, JV; Jiménez-González, M; López-Cancio Martinez, E; Millán-Torné, M; Pérez de la Ossa-Herrero, N | 1 |
| Guo, J; Li, M; Tian, X; Wu, G; Xia, Y; Zhu, M | 1 |
| Abdolghaffari, AH; Aleyasin, AR; Azizi, Y; Chabouk, L; Dehpour, AR; Gooshe, M; Hassanzadeh, GR; Partoazar, A; Payandemehr, B; Tofigh, S | 1 |
| Harada, S; Kageyama, E; Matsuura, W; Tokuyama, S | 1 |
| Abel, T; Chen, C; Liang, X; Liu, R; Ma, J; Su, D; Xi, C | 1 |
| Guo, JC; Tian, XS; Wu, GC; Xia, Y; Yang, R; Zhou, F | 1 |
| Charron, C; Hakim, AM; Plamondon, H; Proulx, G; Schock, SC; Thompson, CS | 1 |
| Chai, W; Gao, CJ; Li, YQ; Niu, L; Ren, PC; Sun, XD; Wang, W; Zhu, C | 1 |
| Lu, ZH; Wang, Q; Xiong, LZ; Yang, J | 1 |
| Su, DS; Wang, XR; Wang, ZH; Zhao, YH; Zheng, YJ | 1 |
| Furuya, H; Inoue, S; Iwata, M; Kawaguchi, M; Konishi, N; Nakamura, M | 1 |
| Martin, WR; McNicholas, LF | 1 |
| Clark, WM; Kelly, RE; Raps, EC; Tong, DC | 1 |
| Chang, LH; Faden, AI; James, TL; Lemke, M; Shirane, R; Weinstein, PR | 1 |
| Baskin, DS; Hosobuchi, Y; Kuroda, H; Lee, NM | 1 |
| Baskin, DS; Grevel, JC; Hosobuchi, Y | 1 |
2 review(s) available for naltrexone and Cerebral Ischemia
| Article | Year |
|---|---|
[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].
Topics: Adult; Alcoholism; Anabolic Agents; Brain Ischemia; Cerebral Angiography; Clenbuterol; Doping in Sports; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Male; Martial Arts; Mechanical Thrombolysis; Naltrexone; Nandrolone; Nandrolone Decanoate; Stanozolol; Steroids; Substance-Related Disorders; Testosterone Propionate; Tissue Plasminogen Activator; Tomography, X-Ray Computed | 2013 |
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
2 trial(s) available for naltrexone and Cerebral Ischemia
| Article | Year |
|---|---|
New and experimental therapeutic roles for naloxone and related opioid antagonists.
Topics: Alcohol Deterrents; Animals; Bipolar Disorder; Blood Pressure; Brain Ischemia; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Respiration; Schizophrenia; Shock; Spinal Injuries | 1984 |
Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Double-Blind Method; Dynorphins; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Neuroprotective Agents; Receptors, Opioid, kappa; Risk Factors; Survival Analysis; Treatment Failure | 2000 |
16 other study(ies) available for naltrexone and Cerebral Ischemia
| Article | Year |
|---|---|
The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.
Topics: Amyloid beta-Protein Precursor; Animals; Brain Ischemia; Cerebral Cortex; Male; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Neurons; Neuroprotective Agents; Quinolines; Receptors, Opioid, delta; Stroke | 2018 |
Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway.
Topics: Animals; Brain Ischemia; Cerebral Arteries; Chromones; Cyclic GMP; Disease Models, Animal; Diterpenes, Clerodane; Male; Morpholines; Naltrexone; NG-Nitroarginine Methyl Ester; Phosphatidylinositol 3-Kinases; Pia Mater; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Neuroprotective effects of lipopolysaccharide and naltrexone co‑preconditioning in the photothrombotic model of unilateral selective hippocampal ischemia in rat.
Topics: Animals; Avoidance Learning; Brain Ischemia; Disease Models, Animal; Functional Laterality; Hippocampus; Injections, Intraventricular; Ischemic Preconditioning; Learning Disabilities; Lipopolysaccharides; Male; Maze Learning; Naltrexone; Neuroprotective Agents; Photic Stimulation; Random Allocation; Rats; Rats, Wistar; Reaction Time; Treatment Outcome | 2019 |
δ-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the rat.
Topics: Activating Transcription Factor 1; Animals; Blotting, Western; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; CD11b Antigen; Cerebrovascular Circulation; Cyclic AMP Response Element-Binding Protein; Infarction, Middle Cerebral Artery; Male; Naltrexone; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Opioid, delta; Reperfusion Injury | 2013 |
Hypoxia/ischemia a key player in early post stroke seizures: modulation by opioidergic and nitrergic systems.
Topics: Analgesics, Opioid; Animals; Brain Ischemia; Cell Hypoxia; Drug Synergism; GABA Antagonists; Male; Mice; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Seizures; Stroke | 2015 |
Unique action mechanisms of tramadol in global cerebral ischemia-induced mechanical allodynia.
Topics: Analgesics, Opioid; Animals; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Male; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Tramadol | 2016 |
The Role of κ Opioid Receptor in Brain Ischemia.
Topics: Animals; Apoptosis; Blotting, Western; Brain Ischemia; Disease Models, Animal; Diterpenes, Clerodane; Male; Mice; Mice, Inbred C57BL; Naltrexone; Receptors, Opioid, kappa; Reperfusion Injury | 2016 |
[Effects of intracerebroventricular injection of delta-opioid receptor agonist TAN-67 or antagonist naltrindole on acute cerebral ischemia in rat].
Topics: Animals; Brain; Brain Ischemia; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Naltrexone; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reperfusion Injury | 2008 |
Protection conferred by Corticotropin-releasing hormone in rat primary cortical neurons against chemical ischemia involves opioid receptor activation.
Topics: Animals; Brain Ischemia; Cell Death; Cells, Cultured; Corticotropin-Releasing Hormone; Dynorphins; Enkephalins; Indoles; Naltrexone; Narcotic Antagonists; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Potassium Cyanide; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, delta; Receptors, Opioid, kappa; RNA, Messenger | 2009 |
Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system.
Topics: Animals; Apoptosis; Arousal; Asphyxia; Behavior, Animal; Blotting, Western; Brain Ischemia; Brain Stem; Enkephalin, Leucine; Fluorescent Antibody Technique; Heart Arrest; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia, Brain; In Situ Nick-End Labeling; Ischemic Preconditioning; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Postural Balance; Rats; Real-Time Polymerase Chain Reaction; Receptors, Opioid, delta; RNA, Small Interfering; Seizures; Survival Analysis | 2012 |
Involvement of delta-and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats.
Topics: Animals; Brain Ischemia; Electroacupuncture; Enkephalin, Methionine; Immunohistochemistry; Ischemic Preconditioning; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Somatostatin | 2007 |
Dose-dependent neuroprotection of delta opioid peptide [D-Ala2, D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats.
Topics: Animals; Behavior, Animal; Brain Ischemia; Cell Death; Dose-Response Relationship, Drug; Enkephalin, Leucine-2-Alanine; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Neurons; Neuroprotective Agents; Prosencephalon; Rats; Rats, Sprague-Dawley | 2007 |
Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia.
Topics: Animals; Brain Ischemia; Cell Survival; Drug Evaluation, Preclinical; Enkephalin, Leucine-2-Alanine; Hippocampus; Male; Naltrexone; Narcotic Antagonists; Neurons; Neuroprotective Agents; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 2007 |
Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
Topics: Adenosine Triphosphate; Amino Acids; Animals; Brain Chemistry; Brain Ischemia; Fatty Acids, Nonesterified; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Naltrexone; Narcotic Antagonists; Rats; Reperfusion | 1990 |
Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13.
Topics: Acute Disease; Animals; Brain Ischemia; Cats; Dynorphins; Enkephalin, Leucine; Male; Naloxone; Naltrexone; Narcotic Antagonists; Peptide Fragments | 1985 |
Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival.
Topics: Animals; Brain Ischemia; Cats; Cerebrovascular Disorders; Consciousness; Diprenorphine; Disease Models, Animal; Male; Morphinans; Movement; Naloxone; Naltrexone; Pupil; Sensation | 1986 |